Login / Signup

Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing.

Wouter SteyaertLydia SagathGerman DemidovVicente A YépezAnna Esteve-CodinaJulien GagneurKornelia EllwangerRonny DerksJanneke M WeissAmber den OudenSimone van den HeuvelHilde SwinkelsNick ZomerMarloes SteehouwerLuke O'GormanGaluh AstutiKornelia NevelingRebecca SchüleJishu XuMatthis SynofzikDanique BeijerHolger HengelLudger SchölsKristl G ClaeysJonathan BaetsLiedewei Van de VondelAlessandra FerliniRita SelvaticiHeba MorsyMarwa Saeed Abd ElmaksoudVolker StraubJuliane MüllerVeronica PiniLuke PerryAnna SarkozyIrina T ZaharievaFrancesco MuntoniEnrico BugiardiniKiran PolavarapuRita HorvathEvan ReidHanns LochmüllerMarco SpinazziMarco Savaresenull nullnull nullnull nullnull nullLeslie MatalongaSteven LaurieHan G BrunnerHolm GraessnerSergi BeltranStephan OssowskiLisenka E L M VissersChristian GilissenAlexander Hoischen
Published in: medRxiv : the preprint server for health sciences (2024)
Solve-RD is a pan-European rare disease (RD) research program that aims to identify disease-causing genetic variants in previously undiagnosed RD families. We utilised 10-fold coverage HiFi long-read sequencing (LRS) for detecting causative structural variants (SVs), single nucleotide variants (SNVs), insertion-deletions (InDels), and short tandem repeat (STR) expansions in extensively studied RD families without clear molecular diagnoses. Our cohort includes 293 individuals from 114 genetically undiagnosed RD families selected by European Rare Disease Network (ERN) experts. Of these, 21 families were affected by so-called 'unsolvable' syndromes for which genetic causes remain unknown, and 93 families with at least one individual affected by a rare neurological, neuromuscular, or epilepsy disorder without genetic diagnosis despite extensive prior testing. Clinical interpretation and orthogonal validation of variants in known disease genes yielded thirteen novel genetic diagnoses due to de novo and rare inherited SNVs, InDels, SVs, and STR expansions. In an additional four families, we identified a candidate disease-causing SV affecting several genes including an MCF2 / FGF13 fusion and PSMA3 deletion. However, no common genetic cause was identified in any of the 'unsolvable' syndromes. Taken together, we found (likely) disease-causing genetic variants in 13.0% of previously unsolved families and additional candidate disease-causing SVs in another 4.3% of these families. In conclusion, our results demonstrate the added value of HiFi long-read genome sequencing in undiagnosed rare diseases.
Keyphrases
  • genome wide
  • copy number
  • gene expression
  • dna methylation
  • computed tomography
  • blood brain barrier
  • health insurance
  • transcription factor